Carnitine, an important cofactor in the transport of fatty acids to the interior of cell mitochondria, is depleted in myocardial tissue of guinea pigs submitted to diphtheric toxin administration. Mortality rates were reduced in these animals by supplying exogenous amounts of carnitine. The accumulation of fatty acids in the cytoplasm of human heart cells reported in cases of diphtheria suggests that carnitine might possibly be depleted in human myocardium as well.
its capacity to synthesize and excrete an exotoxin, responsible for the majority of clinical manifestations of the disease. The control of diphtheria in underdeveloped countries has been difficult, not only because of low primary immunization levels but also due to high virulence and relatively low pathogenicity of the bacteria. As a result, asymptomatic camers as well as patients with subclinical infections are numerous (I). The diphtheria toxin can act on a culture of cells by inhibiting protein synthesis (10) . This is accomplished by catalyzing the coupling of NAD to the cell elongation factor 2 (EF2), which is responsible for the incorporation of amino acids to peptides through soluble tRNA. The catalyst of this reaction is the fragment A of the toxin molecule: NAD' + EF2 + ADP-ribosyl-EF2 + nicotinamide + HC.
According to Pappenheimer (16) , blocking of the protein synthesis by fragment A could lead to serious disturbances in cellular metabolism and consequently to its structure. It is conceivable that the maintenance of protein synthesis is a sine qua non condition to produce the necessary camers for the transport of carnitine across the cardiac cell external membrane, as suggested by Bohmer and Molstad (3) . Carnitine (P-hydroxy-y-Ntrimethylammonium butyrate) is an indispensable cofactor for the transport of fatty acids to the interior of mitochondria, where they are oxidized to obtain ATP. As fatty acids are important fuels to the heart due to higher yield of ATP per molecule of oxidized fatty acid, carnitine is regularly accumulated in the cytoplasm of the cardiac cell so that relatively lower amounts of carnitine are found in circulating blood (1 7) . The dependence of 60-70% of oxidative metabolism in the burning of fatty acids (15) makes imperative the entrance and accumulation of carnitine within the cardiac cell. A possible reduction in the number of camers as an effect of interference in protein synthesis caused by the diphtheric toxin could lead to an impairment in carnitine transport and thus to a loss of carnitine molecules readily utilizable in the oxidative metabolism. Indeed, carnitine depletion from myocardium is a documented characteristic of diphtheria (19) . The same goes to the expected accumulation of fatty acids in the cytoplasm of the heart cell of guinea pigs (7) and of human beings (5). Challoner et al. ( 6 ) attempted to counterbalance this depletion of carnitine by the administration of exogenous amounts of the substance to guinea tips. The treated animals showed a reduction in death b i heart kvolvement. These experiments also showed that carnitine administration after 4 days of treatment was ineffective, indicating no apparent advantage in prolonging it. By increasing the concentration of L-carnitine in the cell culture, Bohmer and Molstad showed that there was a concomitant increase of carnitine uptake by more than 50%.
All the above described results give enough evidence that the administration of carnitine could in some way replenish the cardiac cell loss caused by the C. diphtheriae toxin. Therefore, carnitine treatment was tried by us with the hope that a larger number of myocardial cells would become viable and, consequently, there would be a reduction of clinical signs and a decrease in lethality coefficients related to myocarditis.
Carnitine has been used successfully in patients with systemic deficiency of this metabolite in many instances (8, 18) , showing good oral absorption and absence of toxicological effects. DLCarnitine given to our patients has been also used therapeutically as a component of orexigenic medicines although there is no support for conclusive results of its efficiency in this respect.
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MATERIALS AND METHODS tical analysis. showinrz a maximal value of 11.26 Ulliter. ReAll patients were prospectively observed from their admission to Hospital Estadual Slo Sebastilo (a state hospital exclusively treating communicable diseases in the metropolitan area of Rio de Janeiro). During 1 year, 147 diphtheric patients were admitted and included in this study. Patients who died before 48 h of hospitalization (n = 15) were excluded from comparative analysis since in almost all cases it was impossible to submit them to the entire routine for diagnosis of myocarditis (Fig. 1) . The remaining 132 patients were randomly distributed into two groups: the carnitine-treated group (n = 73) which was given a syrup of 10% DL-carnitine supplied in the chloride salt form by SapchimFournier-Cimag, along with the hospital's routine treatment for diphtheria. The total carnitine dose administered per day was 100 mg/kg of body weight, given in two portions during 4 days of treatment after admission. The control group (n = 59) consisted of patients receiving only routine hospital therapy: antidiphtheric serum in a single endovenous dose (40,000 to 80,000 units), penicillin (procaine + aqueous) in 400,000 units twice a day during 10 days (or erythromycin in those cases of hypersensibility to penicillin) and general support measures. For cardiac failure, the first choice was furosemide (1-2 mg/kg/day); digitalis (digoxin) was restricted to those patients when diuretic administration was useless or to those cases with early severe heart failure. Temporary cardiac pacemakers were implanted in those cases with severe advanced conduction disorders, according to recent experiments (13) . Clinical characteristics of both groups at hospital admission are displayed in Table 1 .
Once bacteriological diagnosis for diphtheria was confirmed, the presence, intensity, and evolution of myocarditis (based on repeated clinical, electrocardiographic, and radiological examinations) were evaluated in all patients. In this respect, it is worthwhile to mention that the levels of creatine kinase MB isoenzyme (EC 2.7.3.2) were also determined in at least two samples of blood per patient as another mean of evaluating heart injury. The determinations of CK-MB, which were based on the immunological inhibition of the M-type subunit of CK (20) , were monitored continuously in a Cary model 118-C recording spectrophotometer with the cell turret maintained at the temperature of 25°C by means of a Forma Scientific circulating water bath. Although reference values for this method range from O-10 units/liter of blood, we obtained our own reference values from eight normal patients of the same age, submitted to statis-RESPIRATORY FAILURE PNEUMONIA HI SEPSIS agents fo; CK-MB assays were supplied by Merck in kit form (No. 15808). Muscular dystrophy of any kind was not present in the cases evaluated by CK-MB, thus increasing heart specificity in elevated levels.
Statistics consisted of a test involving difference of proportions for single samples (2) , to test the hypothesis Ho: p l = p2. A Burroughs model 6700 computer was used to perform all calculations, according to the formula: z = (pl -p2)/u,,-, , in which up,-,, = Jp(l -p) (l/N1 + 1/N2). Statistical signiftcance was reached when P < 0.05. Informed consent was obtained from patients' parents at admission.
RESULTS
Extensive myocardial damage is frequently evidenced by alterations in the physical examination of the cardiovascular system, as is the case of signs of heart failure, low output syndromes, muMed heart sounds, or regurgitant systolic apical murmurs. We observed a significant reduction ( P = 0.0052) in the carnitinetreated group in comparison to the control one of the incidence of such alterations ( Table 2) .
The increase in cardiothoracic index by radiological examination was also significantly lower ( P = 0.04 18) in the carnitinetreated group, compared to control ( Table 2) .
Serial electrocardiograms (Table 2) showed no significant differences in the two groups in respect to the various electrocardiographic changes, although the difference in conduction disturbance incidence of any degree between the two groups was near the level of statistical significance ( P = 0.0655).
CK-MB activities showed no statistical differences among all patients ( Table 2 ), suggesting that carnitine administration has no influence on the early pathogenic process of diphtheric myocarditis itself, when a cellular lesion is associated with permeability alterations of the cytoplasmic membrane, leading to a release of the enzyme. The incidence of cases in which CK-MB levels were the sole sign of myocardial damage was not higher in the carnitine-treated group ( P = 0.0749). Table 3 shows the correlation between the various ranges of CK-MB activities and the clinical evolution of the patients, irrespective of each group. It is noteworthy that CK-MB ranges showed a prognostic value: in those cases within normal (reference) ranges of CK-MB activities, only one patient died due to myocarditis. In this latter case, this result was inconclusive as only a single measurement was obtained 5 days prior to death. Conversely, when CK-MB activities were greater than 20 U/liter, seven patients died because of myocarditis and six had cardiac abnormalities after hospital discharge. Figure 2 shows the overall incidence of myocarditis, which is similar in both groups.
The need for diuretics and/or digitalis in clinical sets of cardiac failure was significantly reduced ( P = 0.0475) in the carnitine- Similarly, the indication to implant temporary cardiac pacemakers for the control of severe conduction disorders was significantly lower ( P = 0.0256) in the carnitine-treated patients (4. I %) in comparison to control (1 3.8%).
Cardiac abnormalities persisted in eight patients of the control group and in 12 patients of the carnitine-treated group. The most frequent abnormalities observed at hospital discharge were electrocardiographic (conduction disturbances such as left anterior hemiblock, necrosis patterns, low QRS complex amplitudes, and repolarization changes), radiological (increased cardiac size), and clinical (systolic apical murmurs and pathological third heart sound).
Although not statistically significant ( P = 0.102), overall lethality indexes were reduced in the carnitine-treated group (8.2%) in comparison with the control group (15.3%), but a significant reduction ( P = 0.013) in lethality could be observed when myocarditis was considered as causa mortis (Table 4) .
DISCUSSION
The increase in CK-MB activities showed greater accuracy in the determination of myocardial involvement. Interestingly, CK-MB levels were relatively constant in most of the two samples collected in each patient: one in the first days after hospitalization and the other approximately 15 days after diphtheria symptoms appeared. This contrasts sharply with CK-MB activity measured in uncomplicated infarction, which decreases in the blood after 12 h due to its rapid clearance in plasma. It is possible then to assume that leakage of CK-MB, which is "constant" in diphtheric myocarditis, is due to a diffused inflammatory process rather than a focal one, not necessarily related to ischemia. It is relevant to note that in 20 cases (six in control and 14 in the carnitinetreated group) CK-MB activity was the sole manifestation of myocardial damage. We could consider such cases as subclinical forms of myocarditis if CK-MB activities alone actually reflect subclinical myocardial damage. Although the difference in the incidence of such subclinical forms was not significant (P = 0.0749), a larger number of cases occurred in the carnitinetreated group. This could be explained as a result of carnitine interference in the natural evolution of diphtheric myocarditis, halting the pathogenic process so that further clinical, electrocardiographic or radiological signs were not evident.
As expected, CK-MB values in both groups were not statistically different, which may indicate that myocarditis is intrinsic to diphtheria and will occur independently of the treatment. One may observe a higher incidence of myocarditis in this work compared to previous reports on the subject (4, 12) . This may be a result of higher accuracy in myocarditis evaluation as evidenced by the determinations of CK-MB activities. Its higher cardiac specificity made possible confirmation of myocardial damage when other methods showed nonspecific and inconclusive findings, such as slight reductions of cardiac sound intensity (four cases), tachycardia (three cases), and discrete T wave alterations ( 14 cases).
The administration of carnitine resulted in decreased incidence of severe forms of myocarditis. Cardiac failure reduction was Overall incidence of myocarditis. No significant difference was observed between the control group and the carnitine-treated group when myocarditis was diagnosed by all methods: clinical, radiological, electrocardiological, and enzymatic assays (P = 0.1736). There was no significant difference either between the control group (six children) and the carnitine-treated group (14 children) when only CK-MB assessment ensured cardiac injury diagnosis (P = 0.074). Table 4 . Specific causes of death in diphtheric patients of therapeutic support to show the above cited benefits, especially control and carnitine-treated groups lower lethality indexes for the carnitine-treated patients. This
Number of cases study suggests that carnitine can play an important role in the treatment of those patients whose pathogenic mechanism inCarnitinevolves carnitine devletion. as is likelv in the case of divhtheria.
Causes of death Control treated
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reflected in therapeutics, where fewer patients needed diuretics and/or digitalis. The decrease in the need of temporary pacemakers with patients with severe conduction disorders in the carnitine-treated group was an important achievement since advanced disturbances in atrioventricular conduction are the most frequent causes of death in diphtheria (9, 14) . But the clearest evidence of the positive action of carnitine therapy was the significantly lower incidence of myocarditis as the specific cause of the patients' death. As a result, only 33.3% of the treated patients died of myocarditis whereas 89% of patients in the control group failed to survive by this specific cause. The use of DL-carnitine instead of L-carnitine as would be desired was adopted because it was the only pharmaceutic form available to us. It is important to mention that the concentration of DL-carnitine employed in the present therapy was 10-fold higher than that used for orexigen stimulation. Higher carnitine amounts were assumed to counterbalance a possible impairment in carnitine transport caused by the presence of the D isomer. Nevertheless, the administration of DL-carnitine gave sufficient
Summary
The electromyographic activity of an upper airway muscle (genioglossus, GG) and the diaphragm were studied in 10 adult and three young anesthetized rabbits during progressive asphyxia induced by airway occlusion. Results were similar for both age groups. Peak inspiratory activity of GG muscle increased more than that of the diaphragm during both the hyperpnea and gasping (P < 0.05). The increase in GG activity during gasping was not significantly different from that during hyperpnea even though an important stimulus, arousal, was absent during gasping. During end stage asphyxia, as the strength of gasps grew weaker, the rate of loss of GG muscle activity was greater than that of the diaphragm. However, GG activity remained greater than that of the diaphragm at the time of the last spontaneous gasp. As asphyxia progressed, inspiratory duration and the inspiratory contour of integrated electromyogram activity of both muscles changed. These data indicate differences in the control mechanism of the genioglossus and diaphragm during acute severe asphyxia. Increased upper airway muscle activity seen during gasping should help preserve upper airway patency and facilitate autoresuscitation by gasping. These observations of coordinated changes in timing and activity of two functionally different respiratory muscles support the concept that gasping is a highly organized function of the respiratory centers. Printed in U.S. A. airway closure by counteracting the airway constricting effects of the negative pressure (1, 8, 10, 16, 22) . When the activity of the airway dilating muscles is depressed relative to that of the thoracic muscles, as occurs during general anesthesia (17) , the normal balance is upset and airway collapse can occur. Upper airway obstruction is believed to prolong an apneic spell when asphyxia depresses upper airway muscle activity, presumably by the loss or delay of the arousal response (18, 25) . Lacking direct observations to support or refute this theory, we have studied the inspiratory time course and peak electromyographic activity of an airway dilating muscle, the genioglossus, and an inspiratory pressure generating muscle, the diaphragm, during progressive asphyxia in an animal model. In these studies we have paid particular attention to the terminal events during asphyxia when failure in the strength of respiratory efforts begins to occur.
MATERIALS AND METHODS
Ten adult New Zealand White rabbits (weight, 1.5-4 kg), anesthetized with pentobarbital (25-40 mg intraperitoneally) and three 4-week-old rabbits (weight, 0.5-0.6 kg) anesthetized with urethane (0.65-1.0 g/kg) were studied. The animals were studied supine with the head fixed at a 90" angle to the spine. The rectal temperature was maintained between 38 and 39°C with an overhead lamp. Fine bipolar wire electrodes (38-gauge, Isomid Beldon) were used to record diaphragm (DIA) and genioglossus (GG) electromyograms (EMG). The diaphragmatic electrodes were inserted through a subcostal incision which was subsequently closed. An anterior midcervical incision was made through the skin and superficial fascia to expose the myelohyoid muscle and the G G electrodes were inserted through the myelohyoid as reported previously (1) . EMG signals were amplified (Grass P15 AC preamplifier) filtered, rectified, and integrated. Animals breathed spontaneously through a tracheal cannula. After recording control activity of DIA and GG, the tracheal airway was occluded. Occurrence of arousal, onset of primary apnea, and the onset ofgasping were noted on the record. Arousal was said to occur if there were spontaneous body movements, changes in tone of muscles of the head and neck, or eye movements. Direct and integrated EMGs as well as tracheal pressures were recorded on a polygraph. In three of 10 adult rabbits,
